²é¿´: 1891  |  »Ø¸´: 5
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

[½»Á÷] ¡¾2015ÄêFDAÅú×¼ÐÂÒ©»ã×Ü¡¿ ÒÑÓÐ4È˲ÎÓë

FDA Approved new Drugs in 2015


                                                                                                                                                                           date time£º2015-2-10
Cardiology/Vascular Diseases
Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Dermatology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Endocrinology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Family Medicine
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Hematology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Immunology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Infections and Infectious Diseases
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Neurology
Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015

Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015

Obstetrics/Gynecology (Women¡¯s Health)
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Oncology
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Pediatrics/Neonatology
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Vaccines
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ò§çïҩѧ żµÄ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÁèÓîÀ׳Ø

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

Сľ³æ¿ÆÑдóʹ\(^o^)/~

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

лл·ÖÏí\(^o^)/~
ÉÏÉÆÈôË®\(^o^)/~2025\(^o^)/~
3Â¥2015-02-11 08:30:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 6 ¸ö»Ø´ð

³ô±¿±¿

ľ³æ (ÕýʽдÊÖ)

°ô°ô

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
2Â¥2015-02-10 19:46:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gatzz_0827

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË
5Â¥2015-02-12 09:17:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

ÒýÓûØÌû:
5Â¥: Originally posted by gatzz_0827 at 2015-02-12 09:17:37
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË

¶¯×÷¿ìµÄ£¬Ó¦¸ÃÔÚÈýÆÚÁÙ´²Ê±¾Í¿ª¶¯ÁË
¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
6Â¥2015-02-12 09:40:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤£¬270Çóµ÷¼Á +7 YXCT 2026-03-01 7/350 2026-03-02 08:29 by houyaoxu
[¿¼ÑÐ] ¹þ¹¤´ó¼ÆËã»úÁõ„ÂÍŶÓÕÐÉú +3 hit_aiot 2026-03-01 5/250 2026-03-02 07:48 by µÃ¹ÃÎÓã111
[¿¼ÑÐ] 0857µ÷¼Á +4 Ò»ll°ë 2026-02-28 5/250 2026-03-02 02:33 by 908055542
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó²ÄÁÏѧ˶298·Ö£¬Çóµ÷¼Á +5 wsl111 2026-03-01 5/250 2026-03-01 23:45 by ĺÓêÐÇÇç
[¿¼ÑÐ] 265·ÖÇóµ÷¼Á²»µ÷רҵºÍѧУÓÐÐÐѧÉÏ¾Í +6 ÀñÌö¡Õæ258 2026-02-28 8/400 2026-03-01 22:50 by jian_
[¿¼ÑÐ] 0856µ÷¼Á +5 ÁõÃÎ΢ 2026-02-28 5/250 2026-03-01 22:30 by wang_dand
[¿¼ÑÐ] 0856»¯¹¤×¨Ë¶Çóµ÷¼Á +12 ¶­boxing 2026-03-01 12/600 2026-03-01 19:45 by ²Ä×Ómomo
[¿¼ÑÐ] 272Çóµ÷¼Á +6 ²Ä×ÏÓл¯ 2026-02-28 6/300 2026-03-01 18:58 by 18137688336
[¿¼ÑÐ] 0856²ÄÁÏÇóµ÷¼Á +11 hyf hyf hyf 2026-02-28 12/600 2026-03-01 18:57 by 18137688336
[¿¼ÑÐ] ²ÄÁÏѧµ÷¼Á +9 ÌáÉñ¶¹É³°ü 2026-02-28 11/550 2026-03-01 18:15 by ms629
[¿¼ÑÐ] »¯¹¤×¨Ë¶348£¬Ò»Ö¾Ô¸985Çóµ÷¼Á +5 ¸¥¸ñ¸ö 2026-02-28 8/400 2026-03-01 17:25 by sunny81
[¿¼ÑÐ] 0856²ÄÁÏÇóµ÷¼Á +4 ÂéÀ±öÏÓã 2026-02-28 4/200 2026-03-01 16:51 by caszguilin
[»ù½ðÉêÇë] ¸Õ¼Óã¬Ã»ÓÐÆÚ¿¯ºÅ£¬µ«ÊÇÔÚÏ߿ɿ´µÄÂÛÎÄ¿ÉÒÔ·ÅΪ´ú±í×÷Âð 10+3 arang1 2026-03-01 3/150 2026-03-01 16:43 by babero
[¿¼ÑÐ] 311Çóµ÷¼Á +6 ͤͤͤ01 2026-03-01 6/300 2026-03-01 15:41 by 324616
[¿¼ÑÐ] ¿ÎÌâ×é½ÓÊÕ²ÄÁÏÀàµ÷¼ÁÑо¿Éú +3 gaoxiaoniuma 2026-02-28 4/200 2026-03-01 14:30 by jjjÈý¿ç
[¿¼ÑÐ] 317Ò»Ö¾Ô¸»ªÄÏÀí¹¤µçÆø¹¤³ÌÇóµ÷¼Á +6 Soliloquy_Q 2026-02-28 11/550 2026-03-01 11:14 by ¸èliekkas
[¿¼²©] ²©Ê¿×Ô¼ö +4 kkluvs 2026-02-28 4/200 2026-03-01 10:19 by 𥰲𥰲
[¿¼ÑÐ] 304Çóµ÷¼Á +3 52hz~~ 2026-02-28 5/250 2026-03-01 00:00 by 52hz~~
[¿¼ÑÐ] 264Çóµ÷¼Á +3 °ÍÀ­°ÍÀ­¸ù556 2026-02-28 3/150 2026-02-28 21:31 by gaoxiaoniuma
[¿¼ÑÐ] 085600²ÄÁϹ¤³ÌÒ»Ö¾Ô¸Öпƴó×Ü·Ö312Çóµ÷¼Á +8 ³ÔÏüÒ¹1 2026-02-28 10/500 2026-02-28 20:27 by L135790
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û